eVisit
PrivateLast Round
Strategic
Jun 25, 2024
Total Funding Raised
$62M
Company Overview
eVisit is a healthcare technology company that offers a virtual care platform designed to enhance outcomes, revenue, and efficiencies for healthcare organizations by connecting physicians with patients and improving healthcare delivery.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eVisit Comparables
Compare eVisit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 98point6 Technologies | 82% | |
| VeeOne Health | 81% | |
| Andor Health | 80% |
eVisit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 25, 2024 | ||||
| Series B | Sep 21, 2021 | ||||
| Series A | Oct 20, 2020 | ||||
| Seed | Jun 1, 2017 | ||||
| Seed | Jul 28, 2015 |
eVisit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University Growth Fund | Series A |
| Goldman Sachs Asset Management Private Equity | Series B |
| Arizona Founders Fund | Seed |
| TVC Capital | Series A |
| Kickstart Fund | Seed, Series A |
| Goldman Sachs Asset Management | Series B |
| Kickstart | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2025
Named a Best in KLAS winner for 2025 in virtual care.
- Feb 5, 2025
Named a Best in KLAS winner for 2025 in virtual care.
Recent news
Latest coverage and updates
- hiresJul 28, 2026
eVisit hired Mags Tamilarasu as chief product officer on Jul 28th '26.
- promotesJul 28, 2026
eVisit promoted Justin Miller to chief operating officer on Jul 28th '26.
eVisit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about eVisit's valuation, stock price, and market status.
Is eVisit a public or private company?
eVisit is a private company.
What is the current stock price of eVisit?
eVisit is a private company with no public stock price. No recent secondary market data is available.
How much is eVisit worth (valuation)?
Valuation information for eVisit is not publicly available.
Can I buy eVisit stock?
eVisit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was eVisit's last funding round?
eVisit's most recent funding round was Series B on September 21, 2021.
Who are the main investors in eVisit?
Key investors in eVisit include TVC Capital, Goldman Sachs Asset Management.
Will eVisit IPO soon?
No public IPO plans have been announced for eVisit.
How can I track eVisit secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eVisit's secondary market activity and sign up for updates.